Crystal Growth Inhibitors for the Prevention of <scp>l</scp> -Cystine Kidney Stones Through Molecular Design

Jeffrey D. Rimer, Zhihua An, Zina Zhu, Michael H. Lee, David S. Goldfarb, Jeffrey A. Wesson, Michael D. Ward

Science · 2010 · 244 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

Crystallization of L-cystine is a critical step in the pathogenesis of cystine kidney stones. Treatments for this disease are somewhat effective but often lead to adverse side effects. Real-time in situ atomic force microscopy (AFM) reveals that L-cystine dimethylester (L-CDME) and L-cystine methylester (L-CME) dramatically reduce the growth velocity of the six symmetry-equivalent {100} steps because of specific binding at the crystal surface, which frustrates the attachment of L-cystine molecules. L-CDME and L-CME produce l-cystine crystals with different habits that reveal distinct binding modes at the crystal surfaces. The AFM observations are mirrored by reduced crystal yield and crystal size in the presence of L-CDME and L-CME, collectively suggesting a new pathway to the prevention of L-cystine stones by rational design of crystal growth inhibitors.

References

26